publications

Experimental Drug Yields Dramatic Weight Loss

NY Times · May 21, 2026, 10:45 AM · Also reported by 4 other sources

People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said.

Read full story on NY Times → More top stories

Also covered by

MarketWatch Lilly’s new experimental shot produced 28% weight loss CNBC Eli Lilly says next-generation weight loss drug clears crucial obesity trial STAT News STAT+: Lilly’s ‘triple-G’ drug leads to bariatric-surgery levels of weight loss in trial Healthline ‘Next-Gen’ GLP-1 Leads to 16% More Weight Loss. Is It Better Than Zepbound?

Aggregated and edited by the Scoop newsroom. We surface news from NY Times alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Experimental Drug Yields Dramatic Weight Loss

Also covered by

More in publications